184 results on '"Chams-Davatchi C"'
Search Results
2. Effects of L-carnitine supplementation on biomarkers of oxidative stress, antioxidant capacity and lipid profile, in patients with pemphigus vulgaris: a randomized, double-blind, placebo-controlled trial
3. Loss of normal anagen hair in pemphigus vulgaris
4. Diagnostic accuracy of BP180 NC16a and BP230-C3 ELISA in serum and saliva of patients with bullous pemphigoid
5. Evaluation of antioxidant enzyme activity and antioxidant capacity in patients with newly diagnosed pemphigus vulgaris
6. Pemphigus vulgaris-associated Kaposiʼs sarcoma: response to paclitaxel and review of the literature
7. The International Criteria for Behçetʼs Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria
8. Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris
9. Extensive Pyoderma Gangrenosum-Like Lesion in Two Cases of Behçe’s Disease, Responding Only to Cyclosporin
10. Muco-Cutaneous Lesions of Behçet’s Disease
11. Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris
12. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis
13. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity
14. Abortive aphthous-like oral lesions: an underreported initial presentation of pemphigus vulgaris
15. A study on plucked hair as a substrate for direct immunofluorescence in pemphigus vulgaris
16. Outcome of pemphigus vulgaris
17. ‘Mucocutaneous’ or ‘cutaneomucosal’ interval: which one is longer in pemphigus vulgaris?
18. Cervicovaginal involvement in pemphigus vulgaris: a clinical study of 77 cases
19. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity
20. Pemphigus and associated environmental factors: a case–control study
21. Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial
22. Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients
23. Relationship of symptoms and signs to death in pemphigus
24. Effects of L-carnitine supplementation on biomarkers of oxidative stress, antioxidant capacity and lipid profile, in patients with pemphigus vulgaris: a randomized, double-blind, placebo-controlled trial
25. Evaluation of Vitamin D Status in Newly Diagnosed Pemphigus Vulgaris Patients
26. Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris
27. Extensive Pyoderma Gangrenosum-Like Lesion in Two Cases of Behçe’s Disease, Responding Only to Cyclosporin
28. Muco-Cutaneous Lesions of Behçet’s Disease
29. Comparison of Oral Aphthae in Behçet’s Disease and Idiopathic Recurrent Aphthous Stomatitis
30. Diagnostic accuracy of BP180 NC16a and BP230-C3 ELISA in serum and saliva of patients with bullous pemphigoid
31. Pemphigus vulgaris-associated Kaposi's sarcoma: response to paclitaxel and review of the literature
32. Cervicovaginal involvement in pemphigus vulgaris: a clinical study of 77 cases
33. Pemphigus and associated environmental factors: a case?control study
34. Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double‐blind, randomized, controlled trial
35. How much improvement is expected in ocular lesions of Behçet's disease treated with pulse cyclophosphamide?
36. Longitudinal Study of Chlorambucil in Ocular Manifestations of Behcet's Disease
37. Comparison of oral aphthae in Behcet's disease and idiopathic recurrent aphthous stomatitis
38. Different aspects of psoriasis arthritis: Analysis of 150 Iranian patients
39. Desmoglein ELISA in the Diagnosis of Pemphigus and Its Correlation with the Severity of Pemphigus Vulgaris
40. Direct immunofluorescence of plucked hair for evaluation of immunologic remission in pemphigus vulgaris.
41. Pemphigus and pregnancy: A 23-year experience.
42. Family impact of pemphigus disease in an Iranian population using the Family Dermatology Life Quality Index.
43. Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgaris.
44. Dermatoscopic and Mucoscopic Features of Lesions in Patients with Behcet's Disease.
45. Behcet's disease in Iran: Analysis of 7641 cases.
46. Iranian guideline for rituximab therapy in pemphigus patients.
47. Trichloroacetic acid as a treatment for persistent oral mucosal lesions in pemphigus vulgaris.
48. "Change over time in the treatment of pemphigus vulgaris between 2004 and 2016 in Iran": A multiple cross-sectional study.
49. Paediatric Behçet's disease in Iran: report of 204 cases.
50. Comparison of ethylenediaminetetraacetic acid-treated desmoglein ELISA and conventional desmoglein ELISA in the evaluation of pemphigus vulgaris in remission.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.